Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

GBIM

GlobeImmune, Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

GBIM:GlobeImmune, Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.20

EXCHANGE

OTCBB

SECTOR

Health Care

GBIM
GlobeImmune, Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
GBIM
GlobeImmune, Inc Stock Information
Latest Close Price$0.20
52-Week Low/High$0.14 - $0.70
Percent Held by Institutions6.92%
Revenue$7,155,408
Net Income$-2,930,793
Cash Flow$-1,207,004
EPS-0.15%
Market Cap$1,144,648
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months-55.78%
Total Return Last 3 Years-93.14%
Total Return Last 5 Years0.00%
Latest Trade DateJan. 18, 2019
GBIM
GlobeImmune, Inc Dividend Payment History

No Data available for Payment History.

GBIM
GlobeImmune, Inc Other Details

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. Co. has three Tarmogen product candidates in clinical evaluation for infectious disease and multiple cancer indications. Co.'s infectious disease product candidates are: GS-4774 for hepatitis B infection; GI-19000 for tuberculosis; GI-2010 for human immunodeficiency virus; and GI-18000 for hepatitis D infection. Co.'s oncology product candidates are: GI-6207 for medullary thyroid cancer; GI-6301 for chordoma; and GI-4000 for resected pancreas cancer, non-small cell lung cancer, and colorectal cancer.

Web Sitewww.globeimmune.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
GlobeImmune, Inc Dividend Stock News and Updates

Jan. 18, 2019CLOSE PRICE INCREASE: GlobeImmune, Inc (OTCBB: GBIM) on 01-18-2019 increased close price > 10% from $0.15 to $0.20

Read more...

Jan. 12, 2019CLOSE PRICE DECREASE: GlobeImmune, Inc (OTCBB: GBIM) on 01-12-2019 decreased close price > 10% from $0.19 to $0.15

Read more...

Jan. 11, 2019CLOSE PRICE INCREASE: GlobeImmune, Inc (OTCBB: GBIM) on 01-11-2019 increased close price > 10% from $0.14 to $0.19

Read more...
More GlobeImmune, Inc Dividend News
Biotechnology Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Affymax Inc (OTCBB: AFFY) on 01-19-2019 increased close price > 10% from $0.02 to $0.02

Read more...

Jan. 19, 2019CLOSE PRICE DECREASE: AVAX Technologies, Inc. (OTCBB: AVXT) on 01-19-2019 decreased close price > 10% from $0.00 to $0.00

Read more...

Jan. 19, 2019CLOSE PRICE DECREASE: Eurotech Ltd. (OTCBB: EUOT) on 01-19-2019 decreased close price > 10% from $0.00 to $0.00

Read more...
More Biotechnology Dividend News
X

Search Dividend Investor